Best Peptides for Inflammation: Evidence, Risks and How to Choose
Review of peptides used to treat inflammation, their evidence base, known risks, and practical guidance on selection and use.
Best Peptides for Inflammation: Evidence, Risks and How to Choose
Peptides are short chains of amino acids that act as signalling molecules in the body. Some show promise in reducing inflammation, but the evidence is uneven and regulatory status varies widely.
What the evidence actually says
Several peptides have been studied for anti-inflammatory effects:
- BPC-157 (Body Protection Compound-157) has shown activity in animal models but human trials remain limited
- TB-500 (Thymosin Beta-4) appears to modulate immune response in preliminary research
- LL-37 and other antimicrobial peptides demonstrate immune-regulatory properties in controlled settings
The gap between animal data and human clinical evidence is significant. Most available studies are small, short-term or conducted in vitro.
Regulatory and safety considerations
Most peptides used for inflammation fall outside FDA approval for this indication. This means:
- Manufacturing standards are not guaranteed
- Purity and potency vary between suppliers
- Long-term safety profiles are incomplete
- Drug interactions are not well-documented
How to choose if you're considering peptides
- Start with your doctor. They can assess whether peptides fit your specific inflammation profile
- Request third-party testing certificates from any supplier
- Understand that "research peptides" means the evidence is still being built
- Watch for claims that outpace the actual study results
- Track your response carefully if you proceed
Inflammation is real and treatment options matter. Peptides may have a role, but that role is not yet settled by the evidence.
https://ratedbypatients.com/guides/best-peptides-for-inflammation-evidence-risks-and-how-to-choose/